Literature DB >> 24215132

Peptide amphiphile containing arginine and fatty acyl chains as molecular transporters.

Amir Nasrolahi Shirazi1, Donghoon Oh, Rakesh Kumar Tiwari, Brian Sullivan, Anju Gupta, Geoffrey D Bothun, Keykavous Parang.   

Abstract

Peptide amphiphiles (PAs) are promising tools for the intracellular delivery of numerous drugs. PAs are known to be biodegradable systems. Here, four PA derivatives containing arginine and lysine conjugated with fatty acyl groups with different chain lengths, namely, PA1: R-K(C14)-R, PA2: R-K(C16)-R, PA3: K(C14)-R-K(C14), and PA4: K(C16)-R-K(C16), where C16 = palmitic acid and C14 = myristic acid, were synthesized through Fmoc chemistry. Flow cytometry studies showed that, among all synthesized PAs, only K(C16)-R-K(C16), PA4 was able to enhance the cellular uptake of a fluorescence-labeled anti-HIV drug 2',3'-dideoxy-3'-thiacythidine (F'-3TC, F' = fluorescein) and a biologically important phosphopeptide (F'-PEpYLGLD) in human leukemia cells (CCRF-CEM) after 2 h incubation. For example, the cellular uptake of F'-3TC and F'-PEpYLGLD was enhanced approximately 7.1- and 12.6-fold in the presence of the PA4 compared to those of the drugs alone. Confocal microscopy of F'-3TC and F'-PEpYLGLD loaded PA4 in live cells showed significantly higher intracellular localization than the drug alone in human ovarian cells (SK-OV-3) after 2 h incubation. The high-performance liquid chromatography (HPLC) results showed that loading of Dox by the peptide amphiphile was 56% after 24 h. The loaded Dox was released (34%) within 48 h intracellularly. The circular dichrosim (CD) results exhibited that the secondary structure of the peptide was changed upon interactions with Dox. Mechanistic studies revealed that endocytosis is the major pathway of the internalization. These studies suggest that PAs containing the appropriate sequence of amino acids, chain length, charge, and hydrophobicity can be used as cellular delivery tools for transporting drugs and biomolecules.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24215132      PMCID: PMC3873380          DOI: 10.1021/mp400539r

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  30 in total

Review 1.  The SH2 domain: versatile signaling module and pharmaceutical target.

Authors:  Kazuya Machida; Bruce J Mayer
Journal:  Biochim Biophys Acta       Date:  2004-11-19

Review 2.  Parameters influencing the stealthiness of colloidal drug delivery systems.

Authors:  Arnaud Vonarbourg; Catherine Passirani; Patrick Saulnier; Jean-Pierre Benoit
Journal:  Biomaterials       Date:  2006-05-02       Impact factor: 12.479

3.  Cellular binding, motion, and internalization of synthetic gene delivery polymers.

Authors:  Gaelen T Hess; William H Humphries; Nicole C Fay; Christine K Payne
Journal:  Biochim Biophys Acta       Date:  2007-08-07

4.  Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Brian Sullivan; Kellen McCaffrey; Dindyal Mandal; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-07-25       Impact factor: 4.939

Review 5.  Critical parameters in drug delivery by intravenous infusion.

Authors:  Robert A Peterfreund; James H Philip
Journal:  Expert Opin Drug Deliv       Date:  2013-04-09       Impact factor: 6.648

6.  Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers.

Authors:  Selma Bulut; Turan S Erkal; Sila Toksoz; Ayse B Tekinay; Turgay Tekinay; Mustafa O Guler
Journal:  Biomacromolecules       Date:  2011-07-07       Impact factor: 6.988

7.  Fatty acid-RGD peptide amphiphile micelles as potential paclitaxel delivery carriers to α(v)β₃ integrin overexpressing tumors.

Authors:  Narashima Murthy Javali; April Raj; Poonam Saraf; Xiaoling Li; Bhaskara Jasti
Journal:  Pharm Res       Date:  2012-07-24       Impact factor: 4.200

8.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

9.  Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery.

Authors:  Jin-Ki Kim; Joel Anderson; Ho-Wook Jun; Michael A Repka; Seongbong Jo
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

10.  Bilayer disruption and liposome restructuring by a homologous series of small Arg-rich synthetic peptides.

Authors:  Guofeng Ye; Anju Gupta; Robert DeLuca; Keykavous Parang; Geoffrey D Bothun
Journal:  Colloids Surf B Biointerfaces       Date:  2009-10-17       Impact factor: 5.268

View more
  9 in total

1.  Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates.

Authors:  Samaneh Mohammadi; Javid Shahbazi Mojarrad; Parvin Zakeri-Milani; Ali Shirani; Samad Mussa Farkhani; Naser Samadi; Hadi Valizadeh
Journal:  Adv Pharm Bull       Date:  2015-03-05

2.  Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration.

Authors:  Shinichi Fukuda; Akhil Varshney; Benjamin J Fowler; Shao-Bin Wang; Siddharth Narendran; Kameshwari Ambati; Tetsuhiro Yasuma; Joseph Magagnoli; Hannah Leung; Shuichiro Hirahara; Yosuke Nagasaka; Reo Yasuma; Ivana Apicella; Felipe Pereira; Ryan D Makin; Eamonn Magner; Xinan Liu; Jian Sun; Mo Wang; Kirstie Baker; Kenneth M Marion; Xiwen Huang; Elmira Baghdasaryan; Meenakshi Ambati; Vidya L Ambati; Akshat Pandey; Lekha Pandya; Tammy Cummings; Daipayan Banerjee; Peirong Huang; Praveen Yerramothu; Genrich V Tolstonog; Ulrike Held; Jennifer A Erwin; Apua C M Paquola; Joseph R Herdy; Yuichiro Ogura; Hiroko Terasaki; Tetsuro Oshika; Shaban Darwish; Ramendra K Singh; Saghar Mozaffari; Deepak Bhattarai; Kyung Bo Kim; James W Hardin; Charles L Bennett; David R Hinton; Timothy E Hanson; Christian Röver; Keykavous Parang; Nagaraj Kerur; Jinze Liu; Brian C Werner; S Scott Sutton; Srinivas R Sadda; Gerald G Schumann; Bradley D Gelfand; Fred H Gage; Jayakrishna Ambati
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

3.  Cyclic peptide-selenium nanoparticles as drug transporters.

Authors:  Amir Nasrolahi Shirazi; Rakesh K Tiwari; Donghoon Oh; Brian Sullivan; Anil Kumar; Yousef A Beni; Keykavous Parang
Journal:  Mol Pharm       Date:  2014-09-17       Impact factor: 4.939

4.  Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine.

Authors:  Amir Nasrolahi Shirazi; Saghar Mozaffari; Rinzhin Tshering Sherpa; Rakesh Tiwari; Keykavous Parang
Journal:  Molecules       Date:  2018-06-26       Impact factor: 4.411

5.  Difatty Acyl-Conjugated Linear and Cyclic Peptides for siRNA Delivery.

Authors:  Hung Do; Meenakshi Sharma; Naglaa Salem El-Sayed; Parvin Mahdipoor; Emira Bousoik; Keykavous Parang; Hamidreza Montazeri Aliabadi
Journal:  ACS Omega       Date:  2017-10-19

6.  Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery.

Authors:  Parvin Zakeri-Milani; Saeedeh Najafi-Hajivar; Muhammad Sarfraz; Ali Nokhodchi; Hamed Mohammadi; Soheila Montazersaheb; Mehri Niazi; Maryam Hemmatzadeh; Mehdi Soleymani-Goloujeh; Behzad Baradaran; Javid Shahbazi Mojarrad; Masoud Farshbaf; Tooba Gholikhani; Hadi Valizadeh
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

Review 7.  Recent advances in peptide-based nanomaterials for targeting hypoxia.

Authors:  Jun Wang; Jing Liu; Zhongxing Yang
Journal:  Nanoscale Adv       Date:  2021-09-03

8.  Palmitic Acid-Conjugated Radiopharmaceutical for Integrin αvβ3-Targeted Radionuclide Therapy.

Authors:  Guangjie Yang; Hannan Gao; Chuangwei Luo; Xiaoyu Zhao; Qi Luo; Jiyun Shi; Fan Wang
Journal:  Pharmaceutics       Date:  2022-06-23       Impact factor: 6.525

9.  Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment.

Authors:  Pengcheng Zhang; Lye Lin Lock; Andrew G Cheetham; Honggang Cui
Journal:  Mol Pharm       Date:  2014-01-29       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.